FDA Drug Application (200793) for LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS by MATRIX LABS

Back to FDA Applications sponsored by MATRIX LABS

Application Number200793
Product Number001
FormTABLET, FOR SUSPENSION; ORAL
Dosage30MG; 50MG; 60MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS
Active IngredientLamivudine; Nevirapine; Zidovudine

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient NEVIRAPINE17
List of drugs with Active Ingredient ZIDOVUDINE17


Back to FDA Applications sponsored by MATRIX LABS